-
77 medical device industry standards will be revised!
Time of Update: 2021-06-01
Medical Network, May 28 News On May 26, the State Food and Drug Administration issued the "2021 Medical Device Industry Standards Establishment and Revision Plan Project Publicity", which determined
-
"Millennium Medicine Capital" Hebei Anguo: 52.01 million yuan prize for outstanding private enterprises to encourage innovation and help growth
Time of Update: 2021-06-01
(Finish) Medical Network News on May 28th, 27th, Anguo City, Hebei Province held a private enterprise innovation and development conference.
(Finish) Medical Network News on May 28th, 27th, Anguo City, Hebei Province held a private enterprise innovation and development conference.
-
Lunan Pharmaceutical ``Axitinib'' was approved for listing
Time of Update: 2021-06-01
This time, Lunan Pharmaceutical's axitinib tablet was approved, which is the first imitation of the product, and it will bring more treatment options for patients with advanced renal cancer.
-
The Food and Drug Administration issued an announcement on the supplementary inspection method for the pseudo-ginsenoside F11 inspection item in Ginseng Yangrong Pills
Time of Update: 2021-06-01
On May 25, the State Food and Drug Administration issued a supplementary test method for the F11 check item of pseudo-ginsenosides in Ginseng Yangrong Pills, a supplementary test method for check item
-
Phase 3 clinical results of innovative peptide-conjugated drugs for the treatment of multiple myeloma are positive
Time of Update: 2021-06-01
On May 25, 2021, Oncopeptides AB announced that its peptide-conjugated drug Pepaxto (melphalan flufenamide) has achieved positive results in a phase 3 clinical trial for the treatment of relapsed/refractory multiple myeloma (R/R MM).
-
Shortage of drugs to ensure supply and price stabilization. Recent work has been announced. Supervision and law enforcement have been stepped up
Time of Update: 2021-06-01
The State-owned Assets Supervision and Administration Commission of the State Council has guided the establishment of a dynamic tracking mechanism for the supply of shortage drugs, and has adopted various measures to ensure sufficient inventory of shortage drugs to ensure supply.
-
Big variety of 5 billion injections, Beite, Poinsettia...4 reviews on the same day
Time of Update: 2021-06-01
Figure 2: The share of TOP5 companies in Omeprazole Sodium for Injection in 2020 Source: Mi Nei. com, China's public medical institutions terminal competition pattern In 2020, in China's public medical institutions, Osaikon will occupy more than 40% of the market share of Omeprazole Sodium for injection.
-
Johnson & Johnson's EGFR/c-Met dual antibody, the first new drug for specific mutations in lung cancer, was approved by the FDA for marketing
Time of Update: 2021-06-01
On May 21, the FDA issued an announcement to accelerate the approval of Johnson & Johnson's Rybrevant (amivantamab-vmjw) for patients with metastatic non-small cell lung cancer (NSCLC) who have advanced EGFR exon 20 insertion mutations after platinum-based chemotherapy.
-
Ningxia wolfberry regional public brand logo, slogan, and mascot released
Time of Update: 2021-06-01
Medical Network, May 27 News On May 26, Wang Zixin, deputy director of the Ningxia Forestry and Grassland Bureau, officially announced the press conference for the Ningxia wolfberry regional public brand launch and the preparations for the 4th wolfberry industry expo held by the Information Office of the Ningxia Hui Autonomous Region Government.
-
What is the future of kinase inhibitors in the past two decades?
Time of Update: 2021-06-01
In the tumor environment characterized by specific molecules, the obvious effects of BCR-ABL and EGFR inhibitors can be observed, which have affected the treatment of cancer in the past 20 years, and promoted the development of cancer treatment in the direction of precision treatment.
-
Yangtze River won 5 blockbuster new products in one fell swoop to impact Renfu's exclusive painkillers
Time of Update: 2021-06-01
Recently, Yangtze River’s product pipeline has been continuously updated: 3 types of generic drug nalbuphine hydrochloride injection have entered the administrative approval stage, and this product is currently only sold by Renfu; 5 generic drugs have been approved for marketing, and 4 of them have been approved for production and deemed to have been used.
-
There is no mutated new coronavirus that poses a substantial threat to existing vaccines
Time of Update: 2021-05-31
When talking about the global new crown epidemic situation at the opening ceremony of the conference, World Health Organization Director-General Tan Desai said that so far, there has not been a mutated new crown virus that can seriously damage the effectiveness of existing vaccines, diagnoses or treatments.
-
Health Commission: 19 new confirmed cases and 2 local cases
Time of Update: 2021-05-31
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on May 26 The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on May 26 The lat
-
congratulate!
Time of Update: 2021-05-31
Chinese aid Hubei expert Wu Hao won the Sasakawa Health Award congratulate!
Congratulations on Chinese aid Hubei expert Wu Hao for winning the Sasakawa Health Award!
The national health administration departments of WHO member states and past winners can propose candidates, and the decision will be made by the World Health Organization Executive Committee.
-
The mutant strain reminds us that we must race against time!
Time of Update: 2021-05-31
my country's new crown vaccination shows "acceleration" mutant strains remind us that we must race against time!
my country's new crown vaccination shows "acceleration" mutant strains remind us that we must race against time!
-
The community transmission chain of the Yingkou epidemic has been basically blocked
Time of Update: 2021-05-31
At present, 520,000 people in Bayuquan District, Yingkou City have completed the third round of full-staff nucleic acid tests, and the results are all negative.
-
Ge Junbo: Keep a bit naive, that is the driving force for innovation
Time of Update: 2021-05-31
The “last bastion” of interventional treatment of coronary artery disease; he led the team for more than ten years of continuous research and developed the first fully biodegradable stent in China which was approved for listing last year; he initiated the doctor innovation club to gather national innovation forces for China Medical has injected more "hard core power.
-
2 new local confirmed cases in 31 provinces, regions and cities in Anhui
Time of Update: 2021-05-31
As of 24:00 on May 24, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 319 confirmed cases (including 3 severe cases), a total of 86,051 cured and discharged cases, and a total of 4,636 deaths.
-
Zhong Nanshan: China's new crown vaccine coverage rate will reach 80% by the end of the year
Time of Update: 2021-05-31
com on the evening of the 28th that by the end of this year, China's new crown virus vaccine coverage rate will reach 80%, the current vaccine production capacity still needs to be strengthened.
-
WHO Expert: The hypothesis that the new coronavirus is a synthetic is meaningless
Time of Update: 2021-05-31
WHO experts: The assumption that the new coronavirus is synthetic is meaningless WHO expert: The hypothesis that the new crown virus is synthetic is meaningless.
WHO expert: The hypothesis that the new crown virus is synthetic is meaningless.
